Send Press Release To Your Friends

PR Title:	GlaxoSmithKline (GSK) commits $1 million in cervical cancer vaccine to new cooperative effort aimed at reducing deaths from women's cancers
PR Summary:	GlaxoSmithKline (GSK) today announced that it has committed $1 million in Cervarix® cervical cancer vaccine to the Pink Ribbon Red Ribbon partnership over the next five years. GSK has also pledged $50,000 to support the program operations. As a result of this donation, more than 10,000 girls and women will have access to vaccination.

	Basic Information
	Your Name* Your Email* Friend's Name Friend's Email 1* 2   3   Your Message